Claire Elizabeth Powers Smith, MD

Assistant Professor, Medicine

Claire Smith
820 Harrison Ave


Dr. Claire Smith, MD received her undergraduate degree from the University of Washington and her medical degree from Duke University, where she also completed her residency. While at Duke, she was the recipient of several research awards and scholarships, and recently published a study examining national trends in end of life care at the Veterans Health Administration.


  • Duke University School of Medicine, MD
  • University of Washington, BA


  • Published on 6/2/2023

    Olivier T, Smith CEP, Haslam A, Addeo A, Prasad V. Quality of life in the adjuvant setting: A meta-analysis of US Food and Drug Administration approved anti-cancer drugs from 2018 to 2022. J Cancer Policy. 2023 Sep; 37:100426. PMID: 37270063.

    Read at: PubMed
  • Published on 9/10/2022

    Smith CEP, Marcom PK, Mitri Z, Ko NY. Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions. Breast Cancer Res Treat. 2022 Nov; 196(1):215-220. PMID: 36087190.

    Read at: PubMed
  • Published on 5/3/2021

    Smith CEP, Prasad V. Assessment of New Molecular Entities Approved for Cancer Treatment in 2020. JAMA Netw Open. 2021 05 03; 4(5):e2112558. PMID: 34047795.

    Read at: PubMed
  • Published on 2/18/2021

    West MT, Smith CE, Kaempf A, Kohs TCL, Amirsoltani R, Ribkoff J, Choung JL, Palumbo A, Mitri Z, Shatzel JJ. CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real-world practice. Eur J Haematol. 2021 May; 106(5):634-642. PMID: 33527479.

    Read at: PubMed
  • Published on 2/1/2021

    Smith CEP, Prasad V. Targeted Cancer Therapies. Am Fam Physician. 2021 02 01; 103(3):155-163. PMID: 33507053.

    Read at: PubMed

View all profiles